周学红, 张晶. 白细胞介素-6和白细胞介素-17与急性心肌梗死相关性的研究进展[J]. 实用临床医药杂志, 2020, 24(1): 128-132. DOI: 10.7619/jcmp.202001033
引用本文: 周学红, 张晶. 白细胞介素-6和白细胞介素-17与急性心肌梗死相关性的研究进展[J]. 实用临床医药杂志, 2020, 24(1): 128-132. DOI: 10.7619/jcmp.202001033
ZHOU Xuehong, ZHANG Jing. Research progress on the correlation between interleukin-6, interleukin-17 and acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 128-132. DOI: 10.7619/jcmp.202001033
Citation: ZHOU Xuehong, ZHANG Jing. Research progress on the correlation between interleukin-6, interleukin-17 and acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 128-132. DOI: 10.7619/jcmp.202001033

白细胞介素-6和白细胞介素-17与急性心肌梗死相关性的研究进展

Research progress on the correlation between interleukin-6, interleukin-17 and acute myocardial infarction

  • 摘要: 随着研究的不断深入,炎症因子与急性心肌梗死(AMI)的相关性越来越受到关注。白细胞介素-6(IL-6)、白细胞介素-17(IL-17)是目前研究较多的炎症因子,其可通过多种途径参与动脉粥样硬化发生及斑块形成,导致斑块的不稳定,促使AMI患者病情进展,从而引起心肌纤维化和左心室重塑等病理改变。大量研究表明, AMI患者检测IL-6、IL-17可进一步评估病情严重程度及预后,可能有助于为临床干预AMI找到新靶点。

     

    Abstract: With the deepening of research, the correlation between inflammatory factors and acute myocardial infarction(AMI)has been paid more and more attention. Inflammatory factors including interleukin-6(IL-6)and interleukin-17(IL-17)are the most studied factors currently, which can participate in atherosclerosis and plaque formation through a variety of ways, and lead to plaque. The instability of plaque promotes the progression of AMI patients, leading to pathological changes such as myocardial fibrosis and left ventricular remodeling. A large number of studies have shown that the detection of IL-6 and IL-17 in AMI patients can further assess the severity and prognosis of the disease, and may find new targets of AMI by clinical intervention.

     

/

返回文章
返回